Drug discovery

GSK takes biological approach to malaria control

Read more

European Biopharma doesn't skimp on R&D

Read more

A new cell therapy approach to Alzheimer's disease

Read more

Capturing the promise of p38 MAPK inhibition

Read more

HIV vaccine remains elusive but antivirals deliver value

Read more

Targeting skeletal muscle to treat type 2 diabetes

Read more

Microbiome-based therapies as anti-cancer agents

Read more

Antibody-drug conjugates come to the fore

Read more

The microbiome and cancer

Read more

The lasting value of small molecule drugs

Read more